Tag: cancer

The “Right Stuff” in Medicine: If we aren’t curing cancer we can’t call ourselves an advanced culture

I have spent a great deal of time observing how modern society reacts to both achievement and decline, and nowhere is this contrast more visible than in the way we collectively respond to technological ambition on one hand and human vulnerability on the other. There is a recurring pattern I cannot ignore, one that surfaces in moments that should otherwise be met with admiration or compassion. Instead, what I often detect is something more complicated—a quiet, sometimes barely concealed satisfaction when success is interrupted, or when prominent individuals are reminded of their own mortality.

I noticed the same pattern in reactions to high-profile technical setbacks, such as rocket failures tied to ambitious space programs. When a launch vehicle explodes or a mission is delayed, the tone in certain corners of the media and commentary ecosystem can shift from analytical to subtly dismissive. It is as if the grander the objective—reaching orbit, returning to the Moon, advancing human presence in space—the more satisfying it becomes for some observers to see that effort fail spectacularly. I do not believe this is universal, but it is present, and it reflects something deeper than mere critique. It reflects a discomfort with ambition itself, particularly when that ambition aims to elevate human capability beyond its current limits.

I have seen that same tone emerge in a very different context: the public reporting of illness, especially serious diagnoses such as cancer among well-known figures. When those diagnoses are announced, the coverage often carries an undertone that goes beyond simple reporting. The message, implicit rather than explicit, is that no level of success, status, or influence insulates a person from biological reality. That part, of course, is true. But what troubles me is when that truth is delivered with an almost leveling satisfaction—an unspoken reassurance that the “lofty” are ultimately brought down to the same plane as everyone else.

I find that reaction deeply problematic. In my view, the proper response to illness—whether it affects a public figure or a private individual—is empathy paired with determination. Determination not merely to treat symptoms, but to fundamentally improve the systems and technologies that govern health outcomes. Instead, what we often see is a cultural normalization of disease, as if the persistence of illnesses like cancer is inevitable and beyond our reach in any meaningful sense.

My perspective has been shaped in part by personal exposure to the healthcare system through family and close observation. I have seen both extraordinary dedication among practitioners and systemic issues that are far more difficult to reconcile. The healthcare industry, particularly in developed nations, is structurally complex and in many ways financially incentive-driven. According to data from the Centers for Medicare & Medicaid Services, U.S. healthcare spending exceeded $4.5 trillion in 2022, representing nearly 18% of GDP.[1] That scale alone introduces distortions—economic, behavioral, and institutional—that are not always aligned with optimal patient outcomes.

I do not believe it is accurate or fair to reduce healthcare professionals to a single characterization. The field contains individuals of remarkable skill and integrity. At the same time, it operates within a framework that often rewards volume over prevention, treatment over cure, and cost expansion over efficiency. These systemic incentives have been widely discussed in policy literature, including analyses from the National Academy of Medicine and the World Health Organization, both of which highlight structural inefficiencies and misaligned incentives as persistent challenges.[2][3]

Where I draw a sharper distinction is in the cultural posture surrounding health and illness. In many ways, modern healthcare systems are built around managing disease rather than eliminating it. Chronic illness management, long-term pharmaceutical dependency, and repeated procedural interventions form the economic backbone of the system. While these approaches save lives and extend survival, they do not always reflect a paradigm aimed at decisive resolution.

This is where I believe the contrast with fields like aerospace engineering becomes instructive. In aerospace, failure is analyzed, corrected, and systematically eliminated through iterative design. The goal is not to manage risk indefinitely, but to reduce it to near zero through engineering discipline. The “right stuff,” a term popularized by Tom Wolfe, captures this blend of analytical rigor and bold experimentation.[4] It is the willingness to push boundaries while refining systems to the point of reliability.

I have long believed that healthcare would benefit from adopting more of that mindset. Instead of accepting certain diseases as enduring features of human existence, the focus should shift toward eradication or, at minimum, transformative mitigation. There are promising developments in this direction. Advances in immunotherapy, gene editing technologies such as CRISPR, and regenerative medicine have begun to change the landscape of what is medically possible.[5][6] In cancer treatment alone, survival rates have improved significantly over the past several decades due to earlier detection and targeted therapies.[7]

However, it is critical to ground expectations in current scientific reality. While substantial progress has been made, there is no single universal cure for cancer at this time, yet.   But by this time, there should be. Cancer is not one disease but a collection of hundreds of distinct conditions, each with unique genetic and environmental drivers.[8] The goal of cancer treatment should be to defeat it. What can be said, with confidence, is that the trajectory of research is accelerating, and breakthroughs that once seemed theoretical are increasingly entering clinical practice.

I believe this distinction matters, particularly when we speak to audiences capable of influencing investment, policy, and innovation. The objective should not be to declare premature victory, but to articulate a clear and urgent mandate: accelerate the transition from disease management to disease elimination wherever scientifically feasible. That requires alignment across research institutions, funding mechanisms, regulatory frameworks, and private-sector innovation.

It also requires a cultural shift. We should not accept illness as something that simply “grounds” individuals or equalizes outcomes. Instead, we should view every diagnosis as a challenge to be solved—systematically, rapidly, and with the same intensity that we apply to other complex engineering problems. That mindset does not diminish humility; it enhances purpose.

I remain optimistic that such a transformation is possible. The convergence of biotechnology, artificial intelligence, and advanced materials science is creating capabilities that did not exist even a decade ago. Machine learning models are already being used to identify drug candidates, predict protein structures, and optimize treatment pathways.[9] Personalized medicine, once an abstract concept, is becoming increasingly tangible as genomic sequencing becomes more accessible.

The question is not whether progress will continue, but whether it will accelerate at a rate commensurate with its potential. That acceleration depends on leadership—across government, industry, and the scientific community. It depends on prioritizing long-term outcomes over short-term financial gain. And it depends on fostering a culture that celebrates breakthroughs rather than fixating on failure.

When I reflect on the reactions I described at the outset—whether to a rocket explosion or a cancer diagnosis—I see them as symptoms of a broader cultural hesitation to embrace ambition fully. There is comfort in the notion that limits are fixed and universal. There is less comfort in confronting the possibility that those limits may be overcome and that doing so requires sustained effort, risk, and transformation.

I do not share that hesitation. I believe that human progress has always depended on challenging perceived constraints, whether in flight, exploration, or medicine. The same spirit that drives us to reach beyond Earth should drive us to eliminate preventable suffering here on it.

In that sense, the future of healthcare and the future of technological advancement are not separate conversations. They are part of the same continuum: the pursuit of a more capable, more resilient, and ultimately more humane civilization. And if we approach that pursuit with the right balance of discipline and daring—the true “right stuff”—then the outcomes we once considered extraordinary may become routine.

—

Footnotes & References

  1. Centers for Medicare & Medicaid Services. National Health Expenditure Data, 2023.
  2. National Academy of Medicine. The Learning Healthcare System: Workshop Summary, 2007.
  3. World Health Organization. Health Systems Financing: The Path to Universal Coverage, 2010.
  4. Wolfe, Tom. The Right Stuff. Farrar, Straus and Giroux, 1979.
  5. National Cancer Institute. Immunotherapy for Cancer, updated 2024.
  6. Doudna, J., & Charpentier, E. “The new frontier of genome engineering with CRISPR-Cas9.” Science, 2014.
  7. American Cancer Society. Cancer Facts & Figures 2025.
  8. Hanahan, D., & Weinberg, R. “Hallmarks of Cancer: The Next Generation.” Cell, 2011.
  9. Jumper, J. et al. “Highly accurate protein structure prediction with AlphaFold.” Nature, 2021.

Rich Hoffman

More about me

Click Here to Protect Yourself with Second Call Defense https://www.secondcalldefense.org/?affiliate=20707

About the Author: Rich Hoffman

Rich Hoffman is an aerospace executive, political strategist, systems thinker, and independent researcher of ancient history, the paranormal, and the Dead Sea Scrolls tradition. His life in high‑stakes manufacturing, high‑level politics, and cross‑functional crisis management gives him a field‑tested understanding of power — both human and unseen.

He has advised candidates, executives, and public leaders, while conducting deep, hands‑on exploration of archaeological and supernatural hotspots across the world.

Hoffman writes with the credibility of a problem-solver, the curiosity of an archaeologist, and the courage of a frontline witness who has gone to very scary places and reported what lurked there. Hoffman has authored books including The Symposium of Justice, The Gunfighter’s Guide to Business, and Tail of the Dragon, often exploring themes of freedom, individual will, and societal structures through a lens influenced by philosophy (e.g., Nietzschean overman concepts) and current events

How Democrats Plan to Win in 2024: A cure for cancer that has been tucked away in their back pocket for decades

For over a decade, I have been saying that there are cures for most cancers. It wasn’t surprising to me that Israel recently announced their successful results with mice and that most cancers are treatable with some of this groundbreaking technology. The skepticism leveled at my claims in the past was that nobody believed that government would purposely kill people by denying them essential medicine. But I think all that was put to rest when we discovered that governments worldwide would do precisely that. We watched them overplay their hands with Covid and the denial that Ivermectin and Hydroxychloroquine could treat the man-made virus unleashed from a Chinese lab. The bottom line is that cancer is big business for the government partnership with big pharma, and we saw just how deep that relationship ran regarding the Covid vaccines. Now with a bit of history behind us, the Covid vaccine looks to be far more dangerous and much more deadly than the virus ever was. Yet watching the government on Covid has taught us much about how evil it can be. Nothing was more evident than putting Covid patients in nursery homes next to other elderly people knowing that the virus would spread and kill many more with weakened immune systems. I would call it murder. But to the kindest minds, we call it patient mismanagement. Either way, the tactical results were obvious. Would government kill people to maintain control over the population? Absolutely, yes! In fact, they would do anything to gain power and keep power. 

That’s why I found it odd that during the campaign, Joe Biden announced that he would find a cure for cancer if he won the presidency. And he has said similar things over the last few years. Now, when I heard that, I knew that there were already cures for cancer that was well-known for many years. And  NMN supplements can actually reverse the aging process. The fountain of youth wasn’t some obscure science fiction any longer. The technology was within reach and known to many. But at present, we are still dealing with a global order that wants to depopulate the earth, to make mankind dumber so they can’t catch on to the schemes of the religious fanatics involved in climate change. Even if Joe Biden wanted to, he wouldn’t be able to unleash a cure for cancer because there is just too much money in people dying to give it up, and the government is a direct benefactor of those deaths. Because it keeps them in power. So how would Joe Biden ever bring about the cure for cancer if big pharma was against it? Well, this is where judging people based on what they do, not what they say, comes in handy. The cure for cancer looks to have been Joe Biden’s secret strategy for a 2024 run all along, and he has been making deals to protect his vision since he was put in office by the Chinese through election fraud. As an elderly person, he directly benefits from this technology and would like to see it in the marketplace. 

Well, Biden’s strange yielding to big pharma when it came to Covid and playing the alliance with the government to the extent that he did, with the executive order regarding the Covid vaccines, is a dead giveaway to a market replacement for the next great crises, one that gets rid of one concern and replaces it with another. If mandatory vaccines could trade off cancer treatment as a guaranteed revenue stream for big pharma, that would allow for releasing that campaign promise in his fourth year, just before the next run. When you watch the Biden people drift through one flop after another, the high vaccine deaths, the terrible economy, the horrendous foreign relations mishaps, the controversy of the classified documents, the Hunter Biden laptop, and the constant talk about his old age, what topic would there be to make everyone forget about all that? A cure for cancer. Few topics would erase everyone’s mind more than this topic because just about everyone knows someone with cancer or has lost people to it. Its one of those deadly diseases that most lingers in the mind of just about everyone, and if Joe Biden’s presidency revealed a cure to it, such as the recent news from the Department of Energy for net energy production that has been talked about as a big technical breakthrough, its easy to see how the political machine is setting up this story. Biden gets re-elected, big pharma trades off cancer treatment for government-sponsored vaccines, and the globalists get to peel away some populations with the side effects of the vaccine surveillance. Those are my thoughts after watching a week of Davos coverage from the World Economic Forum. Public relations were not good this year; many angry people were reporting on their activities, which made me think that they are going to retreat underground again, as they have since essentially since the creation of the United Nations after World War II. They need a win, too, a new technology breakthrough that shows the value of a government/corporate alliance. Cancer cures are just the thing all these radicals have been looking for to save them in 2024. 

Most of that is conjecture based on my thoughts on the matter, of course. But the looming question that has to be answered to all of that is whether the government deliberately allows people to die of cancer while waiting for the right political window to unleash the cure. Well, the answer is yes! They have been caught doing it; they did it with the creation of Covid and the denial of medicine to truly stop the spread with phony methods designed by the World Health Organization to inspire a Great Reset with the China model in charge of the new global economy. Meanwhile, the billionaires stayed away from Davos this year because they have been snuffed out. They have retreated to the background, but they genuinely want Biden or some other puppet to stay in the White House. And Biden knows his role. So to throw society a bone to retain power and push back the pressure of populism is a strategy that they would absolutely be interested in. And this is a trait they have already shown they are willing to do, to kill people off, to retain their own power. Based on everyone’s behavior, the cancer release story makes the most sense about their pending strategies of Democrats, progressives, and global communists. They need a win, and cancer cures are in their back pocket. And many might call all this a conspiracy theory if we already didn’t know about the cures for cancer that have already been so well known. Yet, our medical industry has sat on those findings for decades; when Biden made such declarative statements about the cure for cancer, it was because he already knew. He’s not that smart otherwise. But they are waiting to release it because they think it’s the only way they can beat Trump without election fraud. It is to give people a solution to something that everyone in the world is concerned with. And by releasing it next year, ahead of the 2024 campaign, they hope to buy votes with a chance to live, even though the government itself is the most dangerous organization on planet earth. But people may well forget about all that if only they wouldn’t have to worry about catching cancer.   

Rich Hoffman

Click to buy The Gunfighter’s Guide to Business